HEV seroprevalence can significantly change after re-assessment.

Bura, Maciej; Michalak, Michal; Lagiedo-Zelazowska, Malgorzata; Bukowska, Alicja; Bura, Aleksandra; Mozer-Lisewska, Iwona

Bura, Maciej; Michalak, Michal; Lagiedo-Zelazowska, Malgorzata; Bukowska, Alicja; Bura, Aleksandra; Mozer-Lisewska, Iwona.

Afiliação

Bura M; Department of Infectious Diseases, Hepatology and Acquired Immunodeficiencies, Poznan University of Medical Sciences, Poznan, Poland.
Michalak M; Department of Computer Science and Statistics, Poznan University of Medical Sciences, Poznan, Poland.
Lagiedo-Zelazowska M; Department of Immunology, Chair of Clinical Immunology, Poznan University of Medical Sciences, Poznan, Poland.
Bukowska A; Regional Blood Center in Poznan, Poznan, Poland.
Bura A; Department of Infectious Diseases, Joseph Strus Multidisciplinary City Hospital in Poznan, Poznan, Poland.
Mozer-Lisewska I; Department of Infectious Diseases, Hepatology and Acquired Immunodeficiencies, Poznan University of Medical Sciences, Poznan, Poland.

J Med Virol ; 90(5): 783-785, 2018 05.

Article em En | MEDLINE | ID: mdl-29388686

Assuntos

Hepatite E; Feminino; Genótipo; Anticorpos Anti-Hepatite; Humanos; Imunoglobulina G; Gravidez; Gravidez de Alto Risco; Prevalência; Estudos Soroepidemiológicos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite E Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google